echemi logo
web-logo
slogan
homepage
Product
  • Product
  • Supplier
  • Inquiry

    My ECHEMI

    EN

    Home > Medical News > Medical Research Articles > Tianjing Biologics Announces Completion of First Patient Dosing in Phase 2 Study of TJ107 and PD-1 Combination Treatment in Solid Tumors

    Tianjing Biologics Announces Completion of First Patient Dosing in Phase 2 Study of TJ107 and PD-1 Combination Treatment in Solid Tumors

    • Last Update: 2022-01-24
    • Source: Internet
    • Author: User
    Tags

    silk company

    1 2 addition
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com